Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, Do Cao C, Kelly A, Barge ML, Lacroix L, Dygai I, Vera P, Rusu D, Schneegans O, Benisvy D, Klein M, Roux J, Eberle MC, Bastie D, Nascimento C, Giraudet AL, Le Moullec N, Bardet S, Drui D, Roudaut N, Godbert Y, Morel O, Drutel A, Lamartina L, Schvartz C, Velayoudom FL, Schlumberger MJ, Leenhardt L, Borget I.
N Engl J Med. 2022 Mar 10;386(10):923-932. doi: 10.1056/NEJMoa2111953.
Direct Labeling of Gold Nanoparticles with Iodine-131 for Tumor Radionuclide Therapy.
Zhu M, Zhao L, Lu X.
Int J Nanomedicine. 2024 Nov 13;19:11805-11818. doi: 10.2147/IJN.S484976. eCollection 2024.
Lipid-Peptide-mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer.
Li Q, Zhang L, Lang J, Tan Z, Feng Q, Zhu F, Liu G, Ying Z, Yu X, Feng H, Yi H, Wen Q, Jin T, Cheng K, Zhao X, Ge M.
Adv Sci (Weinh). 2023 Jan;10(3):e2204334. doi: 10.1002/advs.202204334. Epub 2022 Dec 1.
Phase I study of [(131)I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
Thivat E, Rouanet J, Auzeloux P, Sas N, Jouberton E, Levesque S, Billoux T, Mansard S, Molnar I, Chanchou M, Fois G, Maigne L, Chezal JM, Miot-Noirault E, D'Incan M, Durando X, Cachin F.
BMC Cancer. 2022 Apr 15;22(1):417. doi: 10.1186/s12885-022-09495-3.
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
Dekempeneer Y, Massa S, Santens F, Navarro L, Berdal M, Lucero MM, Pombo Antunes AR, Lahoutte T, Van Ginderachter JA, Devoogdt N, D'Huyvetter M.
J Nucl Med. 2023 Dec;64(12):1941-1948. doi: 10.2967/jnumed.123.266381.
Hybrid Protein Nano-Reactors Enable Simultaneous Increments of Tumor Oxygenation and Iodine-131 Delivery for Enhanced Radionuclide Therapy.
Chen J, Liang C, Song X, Yi X, Yang K, Feng L, Liu Z.
Small. 2019 Nov;15(46):e1903628. doi: 10.1002/smll.201903628. Epub 2019 Oct 2.
Correlation analysis between the quantitative parameters of iodine-131 single-photon emission computed tomography-computed tomography thyroid bed uptake and the efficacy of radioactive iodine adjuvant therapy for papillary thyroid cancer.
Mao Y, Lin R, Wang Y, Yu J.
Quant Imaging Med Surg. 2024 May 1;14(5):3665-3675. doi: 10.21037/qims-23-1723. Epub 2024 Apr 26.
Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E, Garin E, Guylligomarc'h A, Olivié D, Boudjema K, Raoul JL.
Radiother Oncol. 2007 Jan;82(1):76-82. doi: 10.1016/j.radonc.2006.11.001. Epub 2006 Dec 4.
Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma.
Li X, Qian Y, Lu X, Xu M, He S, Zhang J, Song S.
J Control Release. 2025 Feb 10;378:849-863. doi: 10.1016/j.jconrel.2024.12.064. Epub 2024 Dec 31.
Radiation dosimetry of [(131) I]ICF01012 in rabbits: Application to targeted radionuclide therapy for human melanoma treatment.
Jouberton E, Perrot Y, Dirat B, Billoux T, Auzeloux P, Cachin F, Chezal JM, Filaire M, Labarre P, Miot-Noirault E, Millardet C, Valla C, Vidal A, Degoul F, Maigne L.
Med Phys. 2018 Nov;45(11):5251-5262. doi: 10.1002/mp.13165. Epub 2018 Sep 24.
